drugset / Trial / NCT01455480

Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn

NCT01455480 ↗

Phase 1/2 Withdrawn Regenera Pharma Ltd
NaSingle-groupOpen-labelTreatment

Summary

The objective of this Trial is to evaluate the performance of RPh201 as a treatment for the healing of partial thickness burns. It is further postulated that deep second degree lesions will benefit from the RPh201 treatment promoting granulation and epithelialization as well as wound closure.

Timeline

Start
2011-12
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject RPh201 Unknown — Topical

Indications

No indication recorded.